The 43rd Annual Meeting of the Japan Neuroscience Society

Session information

Poster

Disorders of Nervous Systems and Treatment

[1P] Neurodegenerative Disorders

Wed. Jul 29, 2020 1:30 PM - 3:30 PM Poster Session

*Videos are available throughout the meeting period.

*Hiroyuki Morino1, Hara Naoyuki2, Matsuda Yukiko1, Hashimoto Kouichi3, Maruyama Hirofumi2, Kawakami Hideshi1 (1.Dept Epidem, RIRBM, Hiroshima Univ, Hiroshima, Japan, 2.Dept Clinical Neuroscience and Therapeutics, Hiroshima Univ, Hiroshima, Japan, 3.Dept of Neurophysiology, Hiroshima Univ, Hiroshima, Japan)

*Yui Tada1, Kodai Kume1, Yukiko Matsuda1, Takashi Kurashige2, Yuhei Kanaya1, Ryosuke Ohsawa1, Hiroyuki Morino1, Hayato Tabu3, Satoshi Kaneko4, Toshihiko Suenaga5, Akira Kakizuka6, Hideshi Kawakami1 (1.Department of Epidemiology Research Institute for Radiology and Medicine Hiroshima University, 2.Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan, 3.Department of Neurology, Kitano Hospital, Osaka, Japan, 4.Department of Neurology, Kansai Medical University, Osaka, Japan, 5.Department of Neurology, Tenri Hospital, Tenri, Japan, 6.Laboratory of Functional Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan)

*Sandip Shah1, Bhawesh Koirala2, Laxman Khanal1, Sarun Koirala1, Gajendra Prasad Rouniyar2 (1.Department of Human Anatomy,B.P. Koirala institute of Health Sciences,Nepal, 2.Department of Clinical Pharamocology and Therapeutics,B.P. Koirala institute of Health Sciences,Nepal)

*Thomas Damien Prevot1, Guanguan Li2, Daniel Knutson2, Yeunus Mian2, Prithu Mondal2, Indira Mendez-David3, Jean-Philippe Guilloux3, Denis David3, James Cook2, Etienne Sibille1,4,5 (1.Campbell Family Mental Health Research Institute of CAMH,Toronto, Canada, 2.Dept of Chemistry and Biochemistry, University of Wisconsin, Milwaukee, USA, 3.CESP/UMRS 1178, Univ Paris-Sud, Fac Pharmacie, INSERM, Universite Paris-Saclay, Chatenay-Malabry, France, 4.Dept of Psychiatry, University of Toronto, Toronto, Canada, 5.Dept of Pharmacology and Toxicology, University of Toronto, Toronto, Canada)

*Tetsuya Asano1, Haruko Nakamura1, Yuko Kawamoto1, Mikiko Tada1, Fumio Nakamura2, Yayoi Kimura3, Yoshio Goshima4, Hiroshi Doi1, Hideyuki Takeuchi1, Fumiaki Tanaka1 (1.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 2.Department of Biochemistry, School of Medicine, Tokyo Women's Medical University, 3.Advanced Medical Research Center, Yokohama City University, 4.Department of Molecular Pharmacology and neurobiology, Yokohama City University Graduate School of Medicine)

×

Authentication

Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.

https://membership.jnss.org/C00/login

×

Please log in with your participant account.
» Participant Log In